Publications by authors named "Alain Gaulier"

Adult T-cell leukemia/lymphoma (ATLL) is a rare medical condition and a diagnosis that ought to be considered for patients living in an area endemic for the HTLV-1 virus (human T-lymphotrophic virus) where a T-cell lymphoproliferative diagnosis has been made. The cutaneous clinical forms may be the first manifestation of the disease. We report here an observation in a 60-year-old Senegalese woman whose skin lesions were sampled to reveal the ATLL immunophenotypic profile CD4+, CD25+, FoxP3-, and CD7-.

View Article and Find Full Text PDF

Vascular Ehlers-Danlos syndrome (vEDS) results from a mutation in the gene encoding alpha-1, type III pro-collagen (COL3A1) and confers fragility to skin, ligament and vascular tissue. We tested the value of skin biopsy for diagnosis of vEDS through an ultrastructure scoring procedure. Study design was a multicentric, case-control, blinded trial consisting of two phases: phase 1 was to identify an ultra-structure score providing the best discriminative value for vEDS and phase 2 was to replicate this result in a different population.

View Article and Find Full Text PDF

Skin manifestations of angioimmunoblastic T-cell lymphoma (AITL) are frequent, sometimes as first manifestations of the disease. In the absence of a specific marker for neoplastic cells, diagnosis of AITL in skin biopsies is often difficult. CD10 and CXCL13 have been recently recognized as characteristic markers of AITL, but have not been yet investigated in the skin.

View Article and Find Full Text PDF

Onchocerciasis is a filarial disease caused by Onchocerca volvuvus which can lead to skin, bladder or ocular signs. The authors report a 6-month history of generalized pruritus and two bilateral and symmetric masses in inguinal areas in a 57-year-old black woman. Skin snips and a biopsy of a subcutaneous nodule were diagnosed as onchocerciasis with hanging groin and the patient was treated with ivermectin with a dramatic improvement.

View Article and Find Full Text PDF
Article Synopsis
  • Long-term use of hydroxyurea (HU) therapy is linked to various skin side effects, including a reported first case of neuroendocrine carcinoma associated with the drug.
  • The patient had been treated with HU for thrombocythemia for two years, but the treatment was stopped due to a skin eruption resembling dermatomyositis.
  • Years later, she developed multiple keratotic lesions and ultimately a Merkel cell carcinoma on her finger, suggesting a potential link to HU while also acknowledging that it could be a coincidence.
View Article and Find Full Text PDF